Metformin Tablet, Extended Release
Product Images NDC 70010-491

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metformin (NDC 70010-491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Met500mg1000s (Met500mg1000s)

Each tablet contains 500 mg of metformin hydrochloride, USP. The tablets are manufactured by Granules India Limited in Hyderabad, India. The package insert for dosage information should be consulted. These tablets are extended-release and should be stored between 20° to 25° C (68° to 77° F). The medication should be kept in a light-resistant container and out of reach of children. This medication should only be dispensed with a prescription from a healthcare provider.*

FDA Label Image

Met500mg100s (Met500mg100s)

This is a description of a medication called Metformin Hydrochloride Extended-Release Tablets, USP that comes in a package of 100 tablets, each containing 500 mg of metformin hydrochloride, USP. The package insert enclosed contains dosage information. It is important to keep this medicine out of children's reach and store it in a light-resistant container between temperatures of 20° to 25° C (68° to 77° F). It is made for Granules Pharmaceuticals Inc., Chantilly, VA, and manufactured by Granules India Limited, Hyderabad - 500 081, India. The information on the prompt LOT is not available.*

FDA Label Image

Met500mg500s (Met500mg500s)

This is a medication named Metformin Hydrochloride Extended-Release in tablet form, with 500mg strength. It is available only with a prescription, and the package contains 500 tablets. The enclosed package insert provides details about dosage. The medication has to be kept out of reach of children and must be stored in a light-resistant container at a temperature of 20° to 25° C (68° to 77° F). It is manufactured by Granules India Limited and distributed by Granules Pharmaceuticals Inc. It comes with a lot number and manufacturing date.*

FDA Label Image

Met750mg100s (Met750mg100s)

This is a description of a medication called Metformin Hydrochloride Extended-Release Tablets, USP. Each tablet contains 750mg of metformin hydrochloride and a package insert is included for dosage information. It is important to keep the medication out of reach of children and to store it at a temperature between 20-25°C. It should be dispensed in a light-resistant container. The medication is manufactured and distributed by Granules Pharmaceuticals Inc. in Chantilly, Virginia and Granules India Limited in Hyderabad, India.*

FDA Label Image

Met750mg500s (Met750mg500s)

Each tablet contains 750 mg of metformin hydrochloride, manufactured by Granules India Limited. The package insert for Metformin Hydrochloride provides extended-release warning suggesting to store the tablets at 20° to 25° C (68° to 77° F) and dispense in a light-resistant container. The tablets are Rx only and must be kept out of reach of children. The manufacturer of the medication is Granules Pharmaceuticals Inc. This information is useful for pharmacists and medical professionals working with Metformin Hydrochloride.*

FDA Label Image

Metformin 500mg Jpg

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg are available in a batch of 5,000 units with an expiry date of MMAYYYY. The medicine should be stored at 20°-25° C (68°~77° F) with excursions permitted within 15°-30° G (59°~86° F). It is recommended to dispense the medication in light-resistant containers. The instruction mentions that it is meant for repacking only. The medicine is manufactured by Granules Pharmaceuticals Inc., Granules India Limited, and its country of origin is India. FG Code for the medicine is 700000001882.*

FDA Label Image

Metformin 750mg Jpg

Metformin Hydrochloride Extended-Release Tablets are available in a batch of 3500 units with a strength of 750 mg. The batch was manufactured in India and has a Mig.Lic.No. of 37/RR/AP/2003/F/R. These tablets have an NDC No. of 70010-492-20 and should be stored between 20°-25° C (68°-77°F), with excursions permitted to 15°-30° C (59°-86° F). Dispensing should be carried out in light-resistant containers. The tablets are for repacking purposes only. The manufacturer is Granules Pharmaceuticals Inc., Granules India Limited Chantilly, VA 20151. No additional information is available from the given text.*

FDA Label Image

Metformin HCl 500mg Jpg

Metformin Hydrochloride Extended-Release Tablets are used for the treatment of type 2 diabetes. The batch contains 5 x 5000 units of 500 mg tablets with various manufacturing and expiration dates. The tablets should be stored in a controlled room temperature of 20°-25° C (68°-77° F) with excursions permitted for 15°-30° C (69°-86° F) in light-resistant containers. This product is not for retail sale and is intended for repacking only. The manufacturer is Granules Pharmaceuticals Inc., Granules India Limited in Chantilly, VA 20151.*

FDA Label Image

Metformin HCl Jpg

Metformin Hydrochloride Extended-Release Tablets, USP 750mg is a medication indicated for the treatment of type 2 diabetes. The batch number, number of units, manufacturing date, expiration date, NDC number, and other important details are clearly printed on the package. The medication should be stored between 20°C and 25°C, with excursions permitted between 15°C and 30°C, and must be dispensed in light-resistant containers. This medication is manufactured by Granules Pharmaceuticals Inc. for repacking only.*

FDA Label Image

Metformin HCl Structure Jpg

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.